Dr. med. Christian Öhlschlegel
Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
Boneberg E, Senn H, Otto F, Dupont-Lampert V, Beer G, Füzesi L, Steininger H, Öhlschlegel C, Hoefer M, Legler D, Fürstenberger G. Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. Br J Cancer 2009; 101:605-14.
18.08.2009Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
18.08.2009Br J Cancer 2009; 101:605-14
Boneberg E-M, Senn H-J, Otto F, Dupont-Lampert V, Beer G M, Füzesi L, Steininger H, Öhlschlegel Christian, Hoefer M M, Legler D F, Fürstenberger G
Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib
Fokt R, Templeton A, Gillessen Sommer S, Öhlschlegel C, Schmid H. Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib. Urol Int 2009; 83:122-4.
27.07.2009Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib
27.07.2009Urol Int 2009; 83:122-4
Fokt Ralf-Michael, Templeton Arnoud, Gillessen Sommer Silke, Öhlschlegel Christian, Schmid Hans-Peter
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
Viale G, Goldhirsch A, Gelber R, Öhlschlegel C, Karlsson P, Crivellari D, Golouh R, Brown R, Price K, Regan M, Castiglione-Gertsch M, Colleoni M, Mallon E, Sonzogni A, Mastropasqua M, Maiorano E, Gusterson B, Giobbie-Hurder A, Coates A. Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. Ann Oncol 2009; 21:245-54.
24.07.2009Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
24.07.2009Ann Oncol 2009; 21:245-54
Viale G, Goldhirsch A, Gelber R D, Öhlschlegel Christian, Karlsson P, Crivellari D, Golouh R, Brown R W, Price K N, Regan M M, Castiglione-Gertsch M, Colleoni M, Mallon E, Sonzogni A, Mastropasqua M G, Maiorano E, Gusterson B A, Giobbie-Hurder A, Coates A S
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
Viale G, Olszewski W, Knox F, Thürlimann B, Price K, Castiglione-Gertsch M, Gelber R, Gusterson B, Goldhirsch A, Orosz Z, Neven P, Öhlschlegel C, Giobbie-Hurder A, Regan M, Coates A, Mastropasqua M, Dell'Orto P, Maiorano E, MacGrogan G, Braye S, Breast International Group Trial 1-98. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol 2008; 26:5569-75.
03.11.2008Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
03.11.2008J Clin Oncol 2008; 26:5569-75
Viale Giuseppe, Olszewski Wojciech P, Knox Fiona, Thürlimann Beat, Price Karen N, Castiglione-Gertsch Monica, Gelber Richard D, Gusterson Barry A, Goldhirsch Aron, Orosz Zsolt, Neven Patrick, Öhlschlegel Christian, Giobbie-Hurder Anita, Regan Meredith M, Coates Alan S, Mastropasqua Mauro G, Dell'Orto Patrizia, Maiorano Eugenio, MacGrogan Gaëtan, Braye Stephen G, Breast International Group Trial 1-98
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group
Viale G, Gusterson B, Goldhirsch A, Price K, Castiglione-Gertsch M, Gelber R, Rusca T, Grigolato P, Braye S, Öhlschlegel C, Pillay K, Kovács A, Brown R, Perin T, Golouh R, Mastropasqua M, Maiorano E, Regan M, Coates A. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. J Clin Oncol 2008; 26:1404-10.
20.03.2008Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group
20.03.2008J Clin Oncol 2008; 26:1404-10
Viale Giuseppe, Gusterson Barry A, Goldhirsch Aron, Price Karen N, Castiglione-Gertsch Monica, Gelber Richard D, Rusca Tiziana, Grigolato Piergiovanni, Braye Stephen, Öhlschlegel Christian, Pillay Komala, Kovács Anikó, Brown Robert W, Perin Tiziana, Golouh Rastko, Mastropasqua Mauro G, Maiorano Eugenio, Regan Meredith M, Coates Alan S
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
Viale G, Coates A, Goldhirsch A, Gelber R, Castiglione-Gertsch M, Gusterson B, Öhlschlegel C, Pillay K, Kovács A, Brown R, Perin T, Golouh R, Price K, Colleoni M, Maiorano E, Maffini F, Mastropasqua M, Regan M, International Breast Cancer Study Group. Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst 2008; 100:207-12.
29.01.2008Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
29.01.2008J Natl Cancer Inst 2008; 100:207-12
Viale Giuseppe, Coates Alan S, Goldhirsch Aron, Gelber Richard D, Castiglione-Gertsch Monica, Gusterson Barry A, Öhlschlegel Christian, Pillay Komala, Kovács Anikó, Brown R W, Perin Tiziana, Golouh Rastko, Price Karen N, Colleoni Marco, Maiorano Eugenio, Maffini Fausto, Mastropasqua Mauro G, Regan Meredith M, International Breast Cancer Study Group
Delayed diagnosis of atypical mycobacterial skin and soft tissue infections in non-immunocompromized hosts
Witteck A, Öhlschlegel C, Boggian K. Delayed diagnosis of atypical mycobacterial skin and soft tissue infections in non-immunocompromized hosts. Scand J Infect Dis 2008; 40:877-80.
01.01.2008Delayed diagnosis of atypical mycobacterial skin and soft tissue infections in non-immunocompromized hosts
01.01.2008Scand J Infect Dis 2008; 40:877-80
Witteck Andrea, Öhlschlegel Christian, Boggian Katia
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98
Viale G, Gusterson B, Goldhirsch A, Price K, Castiglione-Gertsch M, Gelber R, Thürlimann B, Öhlschlegel C, Braye S, Orosz Z, Neven P, Raffoul J, Rasmussen B, Dell'Orto P, Mastropasqua M, Maiorano E, Regan M, Coates A. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98. J Clin Oncol 2007; 25:3846-52.
06.08.2007Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98
06.08.2007J Clin Oncol 2007; 25:3846-52
Viale Giuseppe, Gusterson Barry A, Goldhirsch Aron, Price Karen N, Castiglione-Gertsch Monica, Gelber Richard D, Thürlimann Beat, Öhlschlegel Christian, Braye Stephen, Orosz Zsolt, Neven Patrick, Raffoul Johnny, Rasmussen Birgitte Bruun, Dell'Orto Patrizia, Mastropasqua Mauro G, Maiorano Eugenio, Regan Meredith M, Coates Alan S
Pseudotumor of gout in the patella of a kidney transplant recipient
Staub-Zähner T, Garzoni D, Fretz C, Lampert C, Öhlschlegel C, Wüthrich R, Fehr T. Pseudotumor of gout in the patella of a kidney transplant recipient. Nat Clin Pract Nephrol 2007; 3:345-9.
01.06.2007Pseudotumor of gout in the patella of a kidney transplant recipient
01.06.2007Nat Clin Pract Nephrol 2007; 3:345-9
Staub-Zähner Tanja, Garzoni Daniela, Fretz Christian, Lampert Christoph, Öhlschlegel Christian, Wüthrich Rudolf P, Fehr Thomas
Multitarget stereotactic core-needle breast biopsy (MSBB)--an effective and safe diagnostic intervention for non-palpable breast lesions: a large prospective single institution study
Senn Bahls E, Dupont Lampert V, Öhlschlegel C, Senn H. Multitarget stereotactic core-needle breast biopsy (MSBB)--an effective and safe diagnostic intervention for non-palpable breast lesions: a large prospective single institution study. Breast 2006; 15:339-46.
20.02.2006Multitarget stereotactic core-needle breast biopsy (MSBB)--an effective and safe diagnostic intervention for non-palpable breast lesions: a large prospective single institution study
20.02.2006Breast 2006; 15:339-46
Senn Bahls E, Dupont Lampert V, Öhlschlegel Christian, Senn H-J
Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells
Hungermann D, Buerger H, Öhlschlegel C, Herbst H, Boecker W. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells. BMC cancer 2005; 5:92.
28.07.2005Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells
28.07.2005BMC cancer 2005; 5:92
Hungermann Daniela, Buerger Horst, Öhlschlegel Christian, Herbst Hermann, Boecker Werner
Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer
Varga Z, Zhao J, Öhlschlegel C, Odermatt B, Heitz P. Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer. Histopathology 2004; 44:332-8.
01.04.2004Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer
01.04.2004Histopathology 2004; 44:332-8
Varga Z, Zhao J, Öhlschlegel Christian, Odermatt B, Heitz P U
CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma
Mihic-Probst D, Zhao J, Saremaslani P, Baer A, Öhlschlegel C, Paredes B, Komminoth P, Heitz P. CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma. Anticancer Res 2004; 24:19-26.
07.02.2004CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma
07.02.2004Anticancer Res 2004; 24:19-26
Mihic-Probst Daniela, Zhao Jianming, Saremaslani Parvin, Baer Angela, Öhlschlegel Christian, Paredes Bruno, Komminoth Paul, Heitz Philipp U
Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma
Hurschler D, Borovicka J, Neuweiler J, Öhlschlegel C, Sagmeister M, Meyenberger C, Schmid U. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:507-14.
26.09.2003Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma
26.09.2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:507-14
Hurschler Daniel, Borovicka Jan, Neuweiler Jörg, Öhlschlegel Christian, Sagmeister Markus, Meyenberger Christa, Schmid Ulrico
[Deglutition problems and dyspnea with stridor. Cervical high-grade type osteosarcoma, apparently of extraskeletal origin]
von Büren T, Peter B, Öhlschlegel C, Grossenbacher R. [Deglutition problems and dyspnea with stridor. Cervical high-grade type osteosarcoma, apparently of extraskeletal origin]. HNO 2003; 51:912-4.
25.06.2003[Deglutition problems and dyspnea with stridor. Cervical high-grade type osteosarcoma, apparently of extraskeletal origin]
25.06.2003HNO 2003; 51:912-4
von Büren T, Peter B, Öhlschlegel Christian, Grossenbacher R
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
Jörger M, Öhlschlegel C, Cerny T, Gillessen Sommer S. Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin. Onkologie 2002; 25:558-61.
01.12.2002Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
01.12.2002Onkologie 2002; 25:558-61
Jörger Markus, Öhlschlegel Christian, Cerny Thomas, Gillessen Sommer Silke
The value of percutaneous transpedicular vertebral bone biopsies for histologic examination. Results of an experimental histopathologic study comparing two biopsy needles
Ward J, Jeanneret B, Öhlschlegel C, Magerl F. The value of percutaneous transpedicular vertebral bone biopsies for histologic examination. Results of an experimental histopathologic study comparing two biopsy needles. Spine 1996; 21:2484-90.
01.11.1996The value of percutaneous transpedicular vertebral bone biopsies for histologic examination. Results of an experimental histopathologic study comparing two biopsy needles
01.11.1996Spine 1996; 21:2484-90
Ward J C, Jeanneret B, Öhlschlegel Christian, Magerl F
Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia
Eisterer W, Neyer U, Hilbe W, Diem G, Öhlschlegel C, Ludescher C, Thaler J. Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia. Nephron 1996; 72:468-71.
01.01.1996Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia
01.01.1996Nephron 1996; 72:468-71
Eisterer W, Neyer U, Hilbe W, Diem G, Öhlschlegel Christian, Ludescher C, Thaler J
[Enalapril (Reniten)-associated toxic hepatitis]
Hürlimann R, Binek J, Öhlschlegel C, Hammer B. [Enalapril (Reniten)-associated toxic hepatitis]. Schweizerische medizinische Wochenschrift 1994; 124:1276-80.
23.07.1994[Enalapril (Reniten)-associated toxic hepatitis]
23.07.1994Schweizerische medizinische Wochenschrift 1994; 124:1276-80
Hürlimann R, Binek Janek, Öhlschlegel Christian, Hammer B
Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes
Wehrmann M, Bohle A, Bogenschütz O, Eissele R, Freislederer A, Öhlschlegel C, Schumm G, Batz C, Gärtner H. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 1989; 31:67-76.
01.02.1989Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes
01.02.1989Clin Nephrol 1989; 31:67-76
Wehrmann M, Bohle A, Bogenschütz O, Eissele R, Freislederer A, Öhlschlegel Christian, Schumm G, Batz C, Gärtner H V